info@archbow.com

+1 (321) 355-2686

Pharmaceutical and Biotech Consultancy Services in the USA and Europe

Pharmaceutical Consultants USA, Europe, Pharmaceutical Consulting Services USA, Europe, Biotech Consultants USA, Europe, Biotech Consulting Services USA, Europe, Pharmaceutical Market Access USA, Europe

Archbow Consulting helps pharma and biotech companies design, build, and optimize product distribution and patient access strategies

Archbow’s pharmaceutical and biotech consultants have an average of 20+ years of real-world experience spanning:

Pharma & Biotech Manufacturers

Payers & PBMs

Specialty Pharmacies

Wholesalers

Hubs

3PLs

Distributors

Patient Services Providers

Hospitals

Screen Shot 2021-06-08 at 4.30.48 PM.png

Pharmaceutical Consultants USA, Europe, Pharmaceutical Consulting Services USA, Europe, Biotech Consultants USA, Europe, Biotech Consulting Services USA, Europe, Pharmaceutical Market Access USA, Europe

CASE STUDIES

Market Analysis Informs Biotech Distribution Strategy

Assessment of Hybrid HUB Enables Optimization

Smart Program Evaluation & Contracting

Pharmaceutical Consultants USA, Europe, Pharmaceutical Consulting Services USA, Europe, Biotech Consultants USA, Europe, Biotech Consulting Services USA, Europe, Pharmaceutical Market Access USA, Europe

OUR SERVICES

PRODUCT DISTRIBUTION

PATIENT ACCESS

COMMERCIAL OPTIMIZATION

LATEST NEWS

Meghan Mullooly

6 days ago

How Product Acquisition Impacts Patient Support Offerings: Buy and Bill vs. Specialty Pharmacy

Product Acquistion (Buy and Bill vs. Specialty Pharmacy) is a key factor in determining which services a HUB should offer

Travis Jones

Jun 22

How Pharmaceutical Companies Deliver Successful Patient Access Launch Strategies for Biosimilars

When clients ask how to prepare for a successful launch of patient access strategies for a biosimilar, we advise them to focus on 6 areas

Team Archbow

Jun 11

Optimizing Cross-Functional Collaboration for Compliance and Access

What are the best ways for Patient Services and Compliance to work together for the benefit of the patient? This panel aims to find out.